FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...